Report Detail
Global End-Stage Renal Disease (ESRD) Drugs Market Insights, Forecast to 2025
- RnM2888563 |
- 16 February, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
The global End-Stage Renal Disease (ESRD) Drugs market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the End-Stage Renal Disease (ESRD) Drugs market based on company, product type, end user and key regions.
This report studies the global market size of End-Stage Renal Disease (ESRD) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of End-Stage Renal Disease (ESRD) Drugs in these regions.
This research report categorizes the global End-Stage Renal Disease (ESRD) Drugs market by top players/brands, region, type and end user. This report also studies the global End-Stage Renal Disease (ESRD) Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
Market size by Product
Calcium Succinate
Mk-3866
Pacritinib
Sanguinate
Tesidolumab
Others
Market size by End User
Hospital
Clinic
ICU
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global End-Stage Renal Disease (ESRD) Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of End-Stage Renal Disease (ESRD) Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global End-Stage Renal Disease (ESRD) Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of End-Stage Renal Disease (ESRD) Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of End-Stage Renal Disease (ESRD) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of End-Stage Renal Disease (ESRD) Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 End-Stage Renal Disease (ESRD) Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by Product
- 1.4.2 Calcium Succinate
- 1.4.3 Mk-3866
- 1.4.4 Pacritinib
- 1.4.5 Sanguinate
- 1.4.6 Tesidolumab
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 ICU
- 1.5.5 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size
- 2.1.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue 2014-2025
- 2.1.2 Global End-Stage Renal Disease (ESRD) Drugs Sales 2014-2025
- 2.2 End-Stage Renal Disease (ESRD) Drugs Growth Rate by Regions
- 2.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Regions
- 2.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers
- 3.1.1 End-Stage Renal Disease (ESRD) Drugs Sales by Manufacturers
- 3.1.2 End-Stage Renal Disease (ESRD) Drugs Sales Market Share by Manufacturers
- 3.1.3 Global End-Stage Renal Disease (ESRD) Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers
- 3.2.1 End-Stage Renal Disease (ESRD) Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 End-Stage Renal Disease (ESRD) Drugs Price by Manufacturers
- 3.4 End-Stage Renal Disease (ESRD) Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 End-Stage Renal Disease (ESRD) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers End-Stage Renal Disease (ESRD) Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into End-Stage Renal Disease (ESRD) Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global End-Stage Renal Disease (ESRD) Drugs Sales by Product
- 4.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Product
- 4.3 End-Stage Renal Disease (ESRD) Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global End-Stage Renal Disease (ESRD) Drugs Breakdown Data by End User
6 North America
- 6.1 North America End-Stage Renal Disease (ESRD) Drugs by Countries
- 6.1.1 North America End-Stage Renal Disease (ESRD) Drugs Sales by Countries
- 6.1.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America End-Stage Renal Disease (ESRD) Drugs by Product
- 6.3 North America End-Stage Renal Disease (ESRD) Drugs by End User
7 Europe
- 7.1 Europe End-Stage Renal Disease (ESRD) Drugs by Countries
- 7.1.1 Europe End-Stage Renal Disease (ESRD) Drugs Sales by Countries
- 7.1.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe End-Stage Renal Disease (ESRD) Drugs by Product
- 7.3 Europe End-Stage Renal Disease (ESRD) Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs by Countries
- 8.1.1 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Sales by Countries
- 8.1.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific End-Stage Renal Disease (ESRD) Drugs by Product
- 8.3 Asia Pacific End-Stage Renal Disease (ESRD) Drugs by End User
9 Central & South America
- 9.1 Central & South America End-Stage Renal Disease (ESRD) Drugs by Countries
- 9.1.1 Central & South America End-Stage Renal Disease (ESRD) Drugs Sales by Countries
- 9.1.2 Central & South America End-Stage Renal Disease (ESRD) Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America End-Stage Renal Disease (ESRD) Drugs by Product
- 9.3 Central & South America End-Stage Renal Disease (ESRD) Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs by Countries
- 10.1.1 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Sales by Countries
- 10.1.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs by Product
- 10.3 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs by End User
11 Company Profiles
- 11.1 CTI BioPharma Corp
- 11.1.1 CTI BioPharma Corp Company Details
- 11.1.2 Company Business Overview
- 11.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Products Offered
- 11.1.5 CTI BioPharma Corp Recent Development
- 11.2 Merck & Co Inc
- 11.2.1 Merck & Co Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Products Offered
- 11.2.5 Merck & Co Inc Recent Development
- 11.3 Novartis AG
- 11.3.1 Novartis AG Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Novartis AG End-Stage Renal Disease (ESRD) Drugs Products Offered
- 11.3.5 Novartis AG Recent Development
- 11.4 Prolong Pharmaceuticals LLC
- 11.4.1 Prolong Pharmaceuticals LLC Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Products Offered
- 11.4.5 Prolong Pharmaceuticals LLC Recent Development
- 11.5 VESSL Therapeutics Ltd
- 11.5.1 VESSL Therapeutics Ltd Company Details
- 11.5.2 Company Business Overview
- 11.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Products Offered
- 11.5.5 VESSL Therapeutics Ltd Recent Development
12 Future Forecast
- 12.1 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Regions
- 12.1.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Regions 2019-2025
- 12.2 End-Stage Renal Disease (ESRD) Drugs Market Forecast by Product
- 12.2.1 Global End-Stage Renal Disease (ESRD) Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue Forecast by Product 2019-2025
- 12.3 End-Stage Renal Disease (ESRD) Drugs Market Forecast by End User
- 12.4 North America End-Stage Renal Disease (ESRD) Drugs Forecast
- 12.5 Europe End-Stage Renal Disease (ESRD) Drugs Forecast
- 12.6 Asia Pacific End-Stage Renal Disease (ESRD) Drugs Forecast
- 12.7 Central & South America End-Stage Renal Disease (ESRD) Drugs Forecast
- 12.8 Middle East and Africa End-Stage Renal Disease (ESRD) Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 End-Stage Renal Disease (ESRD) Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on End-Stage Renal Disease (ESRD) Drugs . Industry analysis & Market Report on End-Stage Renal Disease (ESRD) Drugs is a syndicated market report, published as Global End-Stage Renal Disease (ESRD) Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of End-Stage Renal Disease (ESRD) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
